Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · Real-Time Price · USD
9.74
-0.26 (-2.60%)
Oct 7, 2025, 4:00 PM EDT - Market closed

Cartesian Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21
253461107--
Market Cap Growth
-35.04%330.61%---
Enterprise Value
106256123--
Last Close Price
9.7417.9120.68--
PS Ratio
234.6111.844.12--
PB Ratio
--67.74-0.77--
EV/Sales Ratio
103.596.584.75--
Debt / Equity Ratio
-5.28-2.06-0.080.400.18
Debt / EBITDA Ratio
---2.01-
Asset Turnover
0.000.110.111.26-
Quick Ratio
13.119.291.265.766.38
Current Ratio
13.339.431.335.916.42
Return on Equity (ROE)
---70.21%-
Return on Assets (ROA)
-13.65%-6.00%-19.75%10.35%-
Return on Capital (ROIC)
---3021.69%12.98%-
Return on Capital Employed (ROCE)
---10.30%-
Earnings Yield
-14.32%-16.80%-205.34%--
FCF Yield
-17.58%-7.11%-48.01%--
Buyback Yield / Dilution
-203.30%-235.72%-6.33%-27.59%-
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q